Use of selective serotonin reuptake inhibitors and lifestyle among women of childbearing age: A Danish cross-sectional survey

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Laugesen, Kristina ^a   Andersen, Ane Birgitte Telén ^a   Nørgaard, Mette ^a   Nielsen, Rikke Beck ^a   Thomsen, Reimar Wernich ^a   Larsen, Finn Breinholt ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Public Health and Quality Improvement   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL AGE; OBESITY; PHYSICAL ACTIVITY; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; SMOKING; WOMEN'S HEALTH;

EID: 84883401393     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003024     Document Type: Article

References (30)

1. Bennett HA, Einarson A, Taddio A., et al. Prevalence of depression during pregnancy; systematic review. Obstet Gynecol 2004; 103: 698-709. (Pubitemid 40459031)
2. Bennett HA, Einarson A, Taddio A., et al. Depression during pregnancy: overview of clinical factors. Clin Drug Investig 2004; 24: 157-79. (Pubitemid 38445264)
3. Zuckerman B, Amaro H, Baucher H., et al. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet gynecol 1989; 160: 1107-11. (Pubitemid 19144468)
4. Lejoyeux M, Leon E, Rouillon F. Prevalence and risk factors of suicide and attempted suicide. Encephale 1994; 20: 495-503. (Pubitemid 24352064)
5. Bonari L, Pinto N, Ahn E., et al. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004; 49: 726-35. (Pubitemid 40100521)
6. Grote NK, Bridge JA, Gavin A.R., et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-24.
7. Cooper WO, Willy ME, Pont S.J., et al. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007; 196: 544. e1-5.
8. Andrade SE, Raebel MA, Brown J, et al Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198: 194. e1-5.
9. http://www.sst.dk/Nyhedscenter/Nyheder/2007/nye-tal-20-07.aspx (accessed 29 Mar 2013).
10. Wen SW, Yang Q, Garner P., et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194: 961-6.
11. Lund N, Pedersen LH, Henriksen TB Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009; 163: 949-54.
12. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40: 1723-33.
13. Pedersen LH, Henriksen TB, Vestergaard M, et al Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009; 339: b3569.
14. Kieler H, Artama M, Engeland A., et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 339:d8012.
15. Jimenez-Solem E., Andersen JT, Petersen M, et al Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012; 2: e001148.
16. Reis M, Kallen B. Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects: a register study. BMJ Open 2013; 3:e002166.
17. Alwan S, Reefhuis J, Rasmussen S.A., et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356: 2684-92. (Pubitemid 47001036)
18. Rogers JM. Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res C Embryo Today 2008; 84: 1-15. (Pubitemid 351499890)
19. Dennedy MC, Avalos G, ÓReilly MW, et al. The impact of maternal obesity on gestational outcomes. Ir Med J 2012; 105: 23-5.
20. Erickson AC, Arbour LT Heavy smoking during pregnancy as a marker for other risk factors of adverse birth outcomes: a population-based study in British Columbia, Canada. BMC Public Health 2012; 12: 102.
21. Mateja WA, Nelson DB, Kroelinger C.D., et al. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects. J Womens Health (Larchmt) 2012; 21: 26-34.
22. Dawson DA, Grant BF, Stinson F.S., et al. Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations. Drug Alcohol Depend 2005; 77: 139-50. (Pubitemid 40128192)
23. Luppino FS, De Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-9.
24. Cheron-Launay M., Le Faou AL, Sevilla-Dedieu C, et al. Smoking and the consumption of antidepressants, anxiolytics and hypnotic drugs: results of a large, French epidemiological study in 2005. Addict Behav 2011; 36: 743-8.
25. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39: 22-5.
26. Edwards P, Roberts I, Clarke M., et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002; 324: 1183.
27. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html (accessed 29 Mar 2013).
28. Toft U, Kristoffersen LH, Lau C, et al The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur J Clin Nutr 2007; 61: 270-8.
29. http://www.sst.dk/Sundhed%20og%20forebyggelse/Alkohol.aspx (accessed 28 May 2013).
30. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010; 2: 273-9.